Innovation Pharmaceuticals IPIX Stock
Innovation Pharmaceuticals Price Chart
Innovation Pharmaceuticals IPIX Financial and Trading Overview
| Innovation Pharmaceuticals stock price | 0.0005 USD |
| Previous Close | 0.02 USD |
| Open | 0.02 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.02 - 0.02 USD |
| 52 Week Range | 0.01 - 0.06 USD |
| Volume | 455.85K USD |
| Avg. Volume | 290.36K USD |
| Market Cap | 10M USD |
| Beta (5Y Monthly) | 0.221126 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IPIX Valuation Measures
| Enterprise Value | 7.52M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 555.7843 |
| Price/Book (mrq) | 3.8600001 |
| Enterprise Value/Revenue | 417.745 |
| Enterprise Value/EBITDA | -2.319 |
Trading Information
Innovation Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.221126 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.06 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.02 USD |
IPIX Share Statistics
| Avg. Volume (3 month) | 290.36K USD |
| Avg. Daily Volume (10-Days) | 256.84K USD |
| Shares Outstanding | 514.01M |
| Float | 464.95M |
| Short Ratio | N/A |
| % Held by Insiders | 10.09% |
| % Held by Institutions | 0.0020% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -20105.55% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.020% |
| Return on Equity (ttm) | -96.42% |
Income Statement
| Revenue (ttm) | 18K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 18K USD |
| EBITDA | -3243000 USD |
| Net Income Avi to Common (ttm) | -4113000 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.94M USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 803K USD |
| Total Debt/Equity (mrq) | 29.57 USD |
| Current Ratio (mrq) | 0.402 |
| Book Value Per Share (mrq) | 0.005 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2695000 USD |
| Levered Free Cash Flow (ttm) | -1271250 USD |
Profile of Innovation Pharmaceuticals
| Country | United States |
| State | MA |
| City | Wakefield |
| Address | 301 Edgewater Place |
| ZIP | 01880 |
| Phone | 978 921 4125 |
| Website | https://www.ipharminc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. The company's lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
Q&A For Innovation Pharmaceuticals Stock
What is a current IPIX stock price?
Innovation Pharmaceuticals IPIX stock price today per share is 0.0005 USD.
How to purchase Innovation Pharmaceuticals stock?
You can buy IPIX shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Innovation Pharmaceuticals?
The stock symbol or ticker of Innovation Pharmaceuticals is IPIX.
Which industry does the Innovation Pharmaceuticals company belong to?
The Innovation Pharmaceuticals industry is Biotechnology.
How many shares does Innovation Pharmaceuticals have in circulation?
The max supply of Innovation Pharmaceuticals shares is 518.35M.
What is Innovation Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Innovation Pharmaceuticals PE Ratio is now.
What was Innovation Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Innovation Pharmaceuticals EPS is -0.01 USD over the trailing 12 months.
Which sector does the Innovation Pharmaceuticals company belong to?
The Innovation Pharmaceuticals sector is Healthcare.